Mitigating Fugitive Aerosols During Aerosol Delivery via High-Flow Nasal Cannula Devices

References

1. 1.↵
   1. Li J,
   2. Scott JB,
   3. Fink JB,
   4. Reed B,
   5. Roca O,
   6. Dhand R,
   7. et al

   . Optimizing high-flow nasal cannula flow settings in adult hypoxemic patients based on peak inspiratory flow during tidal breathing. Ann Intensive Care 2021;11(1):164.

   OpenUrl
2. 2.↵
   1. Baldomero AK,
   2. Melzer AC,
   3. Greer N,
   4. Majeski BN,
   5. MacDonald R,
   6. Linskens EJ,
   7. Wilt TJ

   . Effectiveness and harms of high-flow nasal oxygen for acute respiratory failure: an evidence report for a clinical guideline from the American College of Physicians. Ann Intern Med 2021;174(7):952-966.

   OpenUrl
3. 3.
   1. Lewis SR,
   2. Baker PE,
   3. Parker R,
   4. Smith AF

   . High-flow nasal cannula for respiratory support in adult intensive care patients. Cochrane Database Syst Rev 2021;3(3):CD010172.

   OpenUrlCrossRef
4. 4.↵
   1. Li J,
   2. Jing GQ,
   3. Scott JB

   . Year in review 2019: High-flow nasal cannula (HFNC) oxygen therapy for adult patients. Respir Care 2020;65(4):545-557.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Li J,
   2. Tu M,
   3. Yang L,
   4. Jing G,
   5. Fink JB,
   6. Burtin C,
   7. et al

   . Worldwide clinical practice of high-flow nasal cannula and concomitant aerosol therapy in critical care practice. Respir Care 2021;66(9):1416-1424.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Li J,
   2. Harnois LJ,
   3. Markos B,
   4. Roberts KM,
   5. Al Homoud S,
   6. Liu J,
   7. et al

   . Epoprostenol delivered via high-flow nasal cannula for ICU subjects with severe hypoxemia comorbid with pulmonary hypertension or right heart dysfunction. Pharmaceutics 2019;11(6):281.

   OpenUrl
7. 7.↵
   1. Li J,
   2. Gurnani PK,
   3. Roberts KM,
   4. Fink JB,
   5. Vines D

   . The clinical impact of flow titration on epoprostenol delivery via high-flow nasal cannula for ICU patients with pulmonary hypertension or right ventricular dysfunction: a retrospective cohort comparison study. JCM 2020;9(2):464.

   OpenUrl
8. 8.↵
   1. Baudin F,
   2. Buisson A,
   3. Vanel B,
   4. Massenavette B,
   5. Pouyau R,
   6. Javouhey E

   . Nasal high flow in management of children with status asthmaticus: a retrospective observational study. Ann Intensive Care 2017;7(1):55.

   OpenUrlPubMed
9. 9.↵
   1. Beuvon C,
   2. Coudroy R,
   3. Bardin J,
   4. Marjanovic N,
   5. Rault C,
   6. Bironneau V,
   7. et al

   . β agonist delivery by high-flow nasal cannula during COPD exacerbation: A prospective physiological study. Respir Care 2021;67(1):9-15; Oct 26: respcare. 09242.

   OpenUrl
10. 10.↵
    1. Li J,
    2. Chen Y,
    3. Ehrmann S,
    4. Wu J,
    5. Xie L,
    6. Fink JB

    . Bronchodilator delivery via high-flow nasal cannula: A randomized controlled trial to compare the effects of gas flows. Pharmaceutics 2021;13(10):1655.

    OpenUrl
11. 11.↵
    1. Li J,
    2. Fink JB,
    3. MacLoughlin R,
    4. Dhand R

    . A narrative review on transnasal pulmonary aerosol delivery. Crit Care 2020;24(1):506.

    OpenUrl
12. 12.↵
    1. Judson SD,
    2. Munster VJ

    . Nosocomial transmission of emerging viruses via aerosol-generating medical procedures. Viruses 2019;11(10):940.

    OpenUrlCrossRefPubMed
13. 13.
    1. Jackson T,
    2. Deibert D,
    3. Wyatt G,
    4. Durand-Moreau Q,
    5. Adisesh A,
    6. Khunti K,
    7. et al

    . Classification of aerosol-generating procedures: a rapid systematic review. BMJ Open Resp Res 2020;7(1):e000730.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Chan VW,
    2. Ng HH,
    3. Rahman L,
    4. Tang A,
    5. Tang KP,
    6. Mok A,
    7. et al

    . Transmission of severe acute respiratory syndrome coronavirus 1 and severe acute respiratory syndrome coronavirus 2 during aerosol-generating procedures in critical care: A systematic review and meta-analysis of observational studies. Crit Care Med 2021;49(7):1159-1168.

    OpenUrl
15. 15.↵
    1. O'Neil CA,
    2. Li J,
    3. Leavey A,
    4. Wang Y,
    5. Hink M,
    6. Wallace M,
    7. et al

    ; Centers for Disease Control and Prevention Epicenters Program. Characterization of aerosols generated during patient care activities. Clin Infect Dis 2017;65(8):1335-1341.

    OpenUrlCrossRef
16. 16.↵
    1. Hui DS,
    2. Chow BK,
    3. Chu LCY,
    4. Ng SS,
    5. Hall SD,
    6. Gin T,
    7. et al

    . Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest 2009;135(3):648-654.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. McGrath JA,
    2. O’Toole C,
    3. Bennett G,
    4. Joyce M,
    5. Byrne MA,
    6. MacLoughlin R

    . Investigation of fugitive aerosols released into the environment during high-flow therapy. Pharmaceutics 2019;11(6):254.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Sethi S,
    2. Barjaktarevic IZ,
    3. Tashkin DP

    . The use of nebulized pharmacotherapies during the COVID-19 pandemic. Ther Adv Respir Dis 2020;14:1753466620954366.

    OpenUrl
19. 19.↵
    1. Fink JB,
    2. Ehrmann S,
    3. Li J,
    4. Dailey P,
    5. McKiernan P,
    6. Darquenne C,
    7. et al

    . Reducing aerosol-related risk of transmission in the era of COVID-19: An interim guidance endorsed by the International Society of Aerosols in Medicine. J Aerosol Med Pulm Drug Deliv 2020;33(6):300-304.

    OpenUrlPubMed
20. 20.↵
    1. Li J,
    2. Fink JB,
    3. Elshafei AA,
    4. Stewart LM,
    5. Barbian HJ,
    6. Mirza SH,
    7. et al

    . Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion. ERJ Open Res 2021;7(1):00519-2020.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Gaeckle NT,
    2. Lee J,
    3. Park Y,
    4. Kreykes G,
    5. Evans MD,
    6. Hogan Jr CJ

    . Aerosol generation from the respiratory tract with various modes of oxygen delivery. Am J Respir Crit Care Med 2020;202(8):1115-1124.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Bem RA,
    2. van Mourik N,
    3. Klein-Blommert R,
    4. Spijkerman IJ,
    5. Kooij S,
    6. Bonn D,
    7. et al

    . Risk of aerosol formation during high-flow nasal cannula treatment in critically ill subjects. Respir Care 2021;66(6):891-896.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Takazono T,
    2. Yamamoto K,
    3. Okamoto R,
    4. Morimoto S,
    5. Izumikawa K,
    6. Mukae H

    . Effects of surgical masks on droplet dispersion under various oxygen delivery modalities. Crit Care 2021;25(1):89.

    OpenUrl
24. 24.↵
    1. Wilson NM,
    2. Marks GB,
    3. Eckhardt A,
    4. Clarke A,
    5. Young F,
    6. Garden FL,
    7. et al

    . The effect of respiratory activity, noninvasive respiratory support, and face masks on aerosol generation and its relevance to COVID-19. Anaesthesia 2021;76(11):1465-1474.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Dhand R,
    2. Li J

    . Coughs and sneezes: their role in transmission of respiratory viral infections, including SARS-CoV-2. Am J Respir Crit Care Med 2020;202(5):651-659.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Perry SA,
    2. Kesser KC,
    3. Geller DE,
    4. Selhorst DM,
    5. Rendle JK,
    6. Hetrzog JH,
    7. et al

    . Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system. Pediatr Crit Care Med 2013;14(5):e250-6.

    OpenUrlPubMed
27. 27.↵
    1. Harnois L,
    2. Alolaiwat A,
    3. Jing G,
    4. Fink JB,
    5. Dhand R,
    6. Li J

    . Efficacy of various mitigation devices in reducing fugitive emissions from nebulizers. Respir Care 2022 [epub ahead of print].
28. 28.↵
    1. Li J,
    2. Scott JB

    . Exploring and creating new evidence in a pandemic plays a crucial role in guiding clinical practice. Respir Care 2021;66(6):1039-1040.

    OpenUrlFREE Full Text
29. 29.↵
    1. Li J,
    2. Gong L,
    3. Fink JB

    . The ratio of nasal cannula gas flow to patient inspiratory flow on transnasal pulmonary aerosol delivery for adults: an in vitro study. Pharmaceutics 2019;11(5):225.

    OpenUrl
30. 30.↵
    1. Li J,
    2. Ehrmann S

    . High-flow aerosol-dispersing versus aerosol-generating procedures. Am J Respir Crit Care Med 2020;202(8):1069-1071.

    OpenUrlCrossRefPubMed